Like most websites The Ophthalmologist uses cookies. In order to deliver a personalized, responsive service and to improve the site, we remember and store information about how you use it. Learn more.

Farhad Hafezi

Medical Director, The ELZA Institute, Zürich; Professor of Ophthalmology, Medical Faculty, University of Geneva; Clinical Professor of Ophthalmology, USC Gayle and Edward Roski Eye Institute, Keck School of Medicine, University of Southern California, Los Angeles

As a post-doc, Farhad Hafezi identified a gene that can completely inhibit light-induced retinal damage in mice. Today his clinical focus is on corneal and refractive laser surgery, and he is a pioneer of corneal collagen cross-linking (CXL) for the treatment of corneal ectatic disorders like keratoconus. Hafezi was instrumental in building IROC in Zurich, where CXL technology underwent clinical development, and is considered a leading expert on the development and translation of this technique, and its multiple applications in the field. A recipient of the Casebeer and ARVO Foundation/Carl Camras Translational Research Award awards, Hafezi founded the charitable Light for Sight Foundation, along with his wife, Nikki.

Register to The Ophthalmologist

Register to access our FREE online portfolio, request the magazine in print and manage your preferences.

You will benefit from:

  • Unlimited access to ALL articles
  • News, interviews & opinions from leading industry experts
  • Receive print (and PDF) copies of The Ophthalmologist magazine